Comment on alemtuzumab and inclusion body myositis

Brain. 2010 May;133(Pt 5):e135; author reply e136. doi: 10.1093/brain/awp275. Epub 2009 Nov 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Myositis, Inclusion Body / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Alemtuzumab